PRDM1 and inflammatory bowel disease: Studies of the Ascl2–Blimp-1 axis suggest Blimp-1 as a critical regulator of IL-10 production in Th17 cells, which, if metabolically dysregulated, can promote the pathology seen in IBD [9].